Skip to main content

Table 5 PPI consumption before surgery and at follow up visits

From: Non-active implantable device treating acid reflux with a new dynamic treatment approach: 1-year results

  Number of subjects (n) Total
n (%)
PPI use related to acid reflux PPI use related to malfunction of the treatment principle of RefluxStop™
Regular daily PPI consumption
 Baseline 50 50 (100%) 50 (100%) 50 (100%)
 6 Months 47 0 (0.0%) 0 0
 1 year 47 1 (2.1%) 1a 0
  1. aOne (1) subject with the device positioned too low, prohibiting the function of the device